Serenity Bioworks Team
We are an effective team with a deep understanding of stress proteins, myeloid cells, and drug discovery.
Cody Shirriff, MSc.
CEO
A devoted scientist intrigued by the potential of a new class of therapeutics, Cody founded Serenity in 2017. He was previously investigating the role of HSPs in kidney epithelial cells.
His current role as CEO is to help build Serenity's team, assess new opportunities, and ensure milestones are accomplished.
Marsela Braunstein, PhD.
VP of Translational Research
Marsela earned her PhD in Immunology from the University of Toronto and has spent 10 years translating scientific discoveries in cancer and autoimmunity.
She is a leader for SER-101's immunological studies and helps guide corporate strategy from a scientist's perspective.
Justin Knapp, PhD.
VP of Discovery
Justin earned his PhD in Biology from the University of Waterloo and has spent 10 years in discovery research.
Justin designs and executes Serenity's early-stage studies.
Spencer earned an MSc in Pharmacy from uWaterloo and he has spent 6 years in discovery research.
Spencer's role involves managing our science team's laboratory, vivarium, and our relations with suppliers, CMOs, and CROs - he does it all.
Spencer Berg, MSc.
COO